Diabetes Flashcards
Approach to unconscious patient with hypoglycaemia
ABCDE
A- guedel
B-O2
C-pulse, BP,IV access
D-GCS
EFG- glucose
specific- IV glucose and then IM glucagon if glucose less than 4mmol/l recheck every 10 mins
Features of ketoacidosis
Hyperglycaemia
ketonuria
acidosis
Clinical features of ketoacidosis
Dehydration (high glucose-osmotic diuresis) tachycardia, hypotension (Acidosis is a negative inotrope)
air hunger- kussmaul respiration - acidosis
smell of ketones
vomiting and abdo pain- hyperkalaemia/ acidosis- paralytic ileus, careful of aspiration pneumonia
signs of precipitating cause
![](https://s3.amazonaws.com/brainscape-prod/system/cm/540/698/134/a_image_thumb.jpg?1518715734)
What happens to potassium in DKA?
Osmotic diuresis takes potassium
dehydration activates RAAS —> further loss
total body K+ low
serum occassionally high or normal
Acidosis—> H+ moved into cells, forcing K+ out
no insulin—> no K+ uptake, until insulin given, where sudden fall
pre-Renal kidney failure- oliguria with failure of K+ excretion
Management of DKA in 1st hour
PANICS
Potassium- measure hourly, omit if anuria suspected or >5.5mmol/l
Acidosis- check venous pH and ketones
Normal saline- 500mls over 15 mins if systolic <90mm, otherwise 1 l over 1hr
Insulin- 0.1 units/kg/hr
Catheter and cultures: urine, blood etc
Stomach aspiration if drowsy, ET tube first if no gag reflex
Examining the diabetic foot
Inspect-including heels
palpate- cap refill and pulses
light touch- finger, cotton wool or monofilament
avoid pinprick testing
vibration sense
ankle jerks- usually absent
’loss of Protective sensation’
vibrationa and light touch lost first
Joint position, temperature (ethyl chloride spray) if time
Stages of diabetic retinopathy
Pre proliferative
cotton-wool spots
infarcts of unmyelinated nerve cell layer in front of retina
>3 blot haemorrhages
venous bleeding and looping
intra-retinal microbascular abnormalities
Proliferative
New vessels around the disc
peripheral new vessels
new vessels on iris- rubeosis
End-stage
Vitreous haemorrhage from fragile vessels
scarring
tractional retinal detachment
blindness
Indications for eye referral
Fall in corrected visual acuity
single cotton wool spot
3 blot haemorrhages
anything macula
new vessels - emergency
Implications of microalbuminuria
nephropathy is associated with increased risk of macro vascular disease
increased mortality (macro vascular disease)
‘detected early with screening
usually tested as unremarkable albumin: creatinine ratio
extra attention to risk factory’s is indicated (smoking, lipids, HTN)
ACEi slows progression of impairment
what Are the effects of nephron loss in hyperglycaemia
![](https://s3.amazonaws.com/brainscape-prod/system/cm/540/698/162/a_image_thumb.jpg?1518718139)
How does Hyperglycaemia lead to nephron loss?
![](https://s3.amazonaws.com/brainscape-prod/system/cm/540/698/175/a_image_thumb.jpeg?1518718042)
Plasma glucose ranges
Diabetes symptoms (e.g. polyuria, polydipsia and unexplained weight loss for Type 1) plus:
a random venous plasma glucose concentration ≥ 11.1 mmol/l or
a fasting plasma glucose concentration ≥ 7.0 mmol/l (whole blood ≥ 6.1 mmol/l) or
two hour plasma glucose concentration ≥ 11.1 mmol/l two hours after 75g anhydrous glucose in an oral glucose tolerance test (OGTT).
With no symptoms diagnosis should not be based on a single glucose determination but requires confirmatory plasma venous determination. At least one additional glucose test result on another day with a value in the diabetic range is essential, either fasting, from a random sample or from the two hour post glucose load. If the fasting random values are not diagnostic the two hour value should be used.
HBA1c ranges
![](https://s3.amazonaws.com/brainscape-prod/system/cm/540/698/183/a_image_thumb.png?1518967879)
Give some presenting symptoms of DM
thirst
polyuria
blurred vision
infections- thrush
weight loss/gain
CVA,CVD
foot ulcers
How do you screen for diabetic renal disease?
Urinary albumin to creatinine ratio
microalbuminuria- earliest indicator of diabetic nephropathy
ACR>2.5 or 3.5 in men
treatment:
glycaemic controlBP
ACEi/ AngII receptor blocker (renoprotective)